You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Preleukemia

Showing 1 - 25 of 1,380
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lower Risk MDS Per IPSS-R Trial (Luspatercept)

Not yet recruiting
  • Lower Risk MDS Per IPSS-R
  • (no location specified)
Jun 21, 2023

Preleukemia, MDS, Cytopenia Trial in Copenhagen (Metformin)

Recruiting
  • Preleukemia
  • +2 more
  • Copenhagen, Copenhagen N, Denmark
    Rigshospitalet
Jan 20, 2022

MDS Trial (Yisui granule, Placebo)

Not yet recruiting
  • MDS
  • Yisui granule
  • Placebo
  • (no location specified)
Jan 13, 2023

Biospecimen Acquisition for Myelodysplastic Syndromes

Recruiting
  • Myelodysplastic Syndromes
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 20, 2022

    Haplo-HSCT for Elderly Acute Leukemia/ Myelodysplastic Syndrome

    Not yet recruiting
    • Acute Leukemia
    • Myelodysplastic Syndromes
      • Beijing, Beijing, China
        Peking University People's Hospital
      Jun 5, 2023

      MDS Trial run by the National Cancer Institute (NCI) (KPT-8602, Inqovi)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jun 30, 2023

      MDS Trial (Imetelstat)

      Available
      • Myelodysplastic Syndromes
      • (no location specified)
      Jun 30, 2023

      High Grade MDS Trial in Aurora (Omacetaxine, Azacitidine)

      Recruiting
      • High Grade Myelodysplastic Syndromes
      • Aurora, Colorado
        Universtiy of Colorado Denver
      Nov 17, 2022

      MDS Trial run by the National Cancer Institute (NCI) (decitabine and cedazuridine, BMS-986253)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 17, 2022

      MDS Trial (Fasting-mimicking diet (FMD) and physiotherapy)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Fasting-mimicking diet (FMD) and physiotherapy
      • (no location specified)
      Jun 22, 2022

      Lower-risk Myelodysplastic Syndrome Trial in Tampa (JSP191)

      Recruiting
      • Lower-risk Myelodysplastic Syndrome
      • Tampa, Florida
        Moffitt Cancer Center
      Jun 20, 2023

      Acute Myeloid Leukemia, MDS Trial (Galinpepimut-S)

      Available
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndromes
      • Galinpepimut-S
      • (no location specified)
      Oct 20, 2022

      MDS Trial (Hetrombopag)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • (no location specified)
      May 23, 2022

      Interplay Between Immune and Metabolic Programs in

      Recruiting
      • Myelodysplastic Syndromes
        • Toulouse, France
          IUCT-Oncopole University Hospital
        May 17, 2022

        Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • High-Risk and Very High-Risk Myelodysplastic Syndromes
        • (no location specified)
        Jul 25, 2023

        MDS, Ferroptosis Trial in Pessac (Biological sampling)

        Not yet recruiting
        • Myelodysplastic Syndromes
        • Ferroptosis
        • Biological sampling
        • Pessac, France
        • +2 more
        Jun 19, 2023

        Myelodysplastic Syndrome Trial in Nagoya, Fukuoka, Tokyo (SyB L-1101)

        Completed
        Has Results
        • Myelodysplastic Syndrome
        • SyB L-1101
        • Nagoya, Aichi, Japan
        • +2 more
        Nov 14, 2022

        MDS, Myelodysplastic Anemia, Myelodysplastic Syndrome With Isolated Del(5Q) Trial (description of MDS pzatient cohort)

        Recruiting
        • Myelodysplastic Syndromes
        • +5 more
        • description of MDS pzatient cohort
        • Brest, France
          Chu Brest
        Oct 27, 2022

        MDS Trial in Beijing (Roxadustat, Luspatercept)

        Not yet recruiting
        • Myelodysplastic Syndromes
        • Beijing, China
          Peking union medical college hospital
        Aug 17, 2023

        MDS Trial (Decitabine/Cedazuridine, Magrolimab)

        Not yet recruiting
        • Myelodysplastic Syndromes
        • (no location specified)
        Apr 18, 2023

        Myelodysplastic Syndrome Trial in Japan (SyB C-1101)

        Completed
        Has Results
        • Myelodysplastic Syndrome
        • SyB C-1101
        • Nagoya, Aichi, Japan
        • +3 more
        Nov 14, 2022

        Physical Activity in Transfusion Dependent Myelodysplastic

        Recruiting
        • Myelodysplastic Syndromes
        • Medical Device Usage and Evaluation
        • +3 more
        • Philadelphia, Pennsylvania
          Sidney Kimmel Cancer Center at Thomas Jefferson University
        Aug 16, 2022

        MDS, MDS, Thrombocytopenia Trial (Placebo, Romiplostim)

        Completed
        Has Results
        • MDS
        • +2 more
        • Placebo
        • Romiplostim
        • (no location specified)
        Nov 4, 2022

        Myelodysplastic Syndrome (MDS) Trial in Yamagata (ASTX030)

        Recruiting
        • Myelodysplastic Syndrome (MDS)
        • Yamagata, Japan
          Yamagata University Hospital
        Jun 20, 2022

        Minimisation Measures for REBLOZYL Among Healthcare

        Active, not recruiting
        • Myelodysplastic Syndromes
        • Beta-thalassemia
          • City, State, Austria
            Local Institution
          Aug 4, 2022